| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
13,370 |
12,130 |
$297K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
673 |
663 |
$102K |
| 99199 |
Unlisted special service, procedure or report |
1,865 |
1,645 |
$93K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
717 |
709 |
$60K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,603 |
3,444 |
$38K |
| 80053 |
Comprehensive metabolic panel |
5,552 |
5,138 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
788 |
765 |
$27K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
289 |
286 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
817 |
775 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,185 |
5,648 |
$21K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
128 |
128 |
$18K |
| 71045 |
Radiologic examination, chest; single view |
2,120 |
2,055 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
579 |
509 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
536 |
496 |
$8K |
| 84484 |
|
1,863 |
1,591 |
$7K |
| 70450 |
Computed tomography, head or brain; without contrast material |
164 |
163 |
$6K |
| 83690 |
|
1,792 |
1,706 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
433 |
391 |
$6K |
| 81025 |
|
1,866 |
1,793 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,451 |
1,282 |
$5K |
| 81001 |
|
2,790 |
2,670 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
223 |
222 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,089 |
755 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,281 |
1,203 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
129 |
126 |
$4K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
50 |
50 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,183 |
1,142 |
$3K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
148 |
143 |
$3K |
| 87631 |
|
92 |
92 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
234 |
228 |
$2K |
| 81003 |
|
1,964 |
1,900 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
363 |
343 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
224 |
193 |
$2K |
| 87581 |
|
128 |
128 |
$2K |
| 87486 |
|
116 |
116 |
$2K |
| 83605 |
|
348 |
313 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
181 |
154 |
$1K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
223 |
205 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,040 |
926 |
$1K |
| 83880 |
|
61 |
57 |
$855.39 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
41 |
38 |
$764.75 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
19 |
16 |
$745.88 |
| 83735 |
|
209 |
193 |
$625.48 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
121 |
83 |
$436.45 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
98 |
87 |
$386.56 |
| 87040 |
|
76 |
54 |
$379.70 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
110 |
106 |
$367.27 |
| 82553 |
|
48 |
45 |
$355.98 |
| J3490 |
Unclassified drugs |
106 |
89 |
$314.96 |
| 85610 |
|
169 |
167 |
$251.52 |
| 82550 |
|
60 |
57 |
$209.20 |
| 85379 |
|
39 |
39 |
$116.04 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
24 |
$114.68 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
12 |
12 |
$108.75 |
| 85730 |
|
36 |
36 |
$96.31 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
42 |
42 |
$77.16 |
| 87081 |
|
12 |
12 |
$51.28 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
14 |
12 |
$44.36 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13 |
12 |
$42.08 |
| 36415 |
Collection of venous blood by venipuncture |
80 |
66 |
$29.24 |
| 0270 |
|
34 |
26 |
$19.99 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
15 |
15 |
$12.34 |
| 87186 |
|
13 |
13 |
$8.69 |
| J7050 |
Infusion, normal saline solution, 250 cc |
29 |
15 |
$6.95 |
| A9270 |
Non-covered item or service |
23 |
16 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
12 |
12 |
$0.00 |